Works by Reyderman, L

Results: 11

Eribulin mesylate pharmacokinetics in patients with solid tumors receiving repeated oral ketoconazole.

Published in:

Investigational New Drugs, 2013, v. 31, n. 2, p. 381, doi. 10.1007/s10637-012-9829-3

By:

Devriese, L.;
Mergui-Roelvink, M.;
Wanders, J.;
Jenner, A.;
Edwards, G.;
Reyderman, L.;
Copalu, W.;
Peng, F.;
Marchetti, S.;
Beijnen, J.;
Schellens, J.

Publication type:

Article

Disposition of loratadine in healthy volunteers.

Published in:

Xenobiotica, 2007, v. 37, n. 7, p. 753, doi. 10.1080/00498250701463317

By:

Ramanathan, R.;
Reyderman, L.;
Kulmatycki, K.;
Su, A.-D.;
Alvarez, N.;
Chowdhury, S. K.;
Alton, K. B.;
Wirth, M. A.;
Clement, R. P.;
Statkevich, P.;
Patrick, J. E.

Publication type:

Article

Disposition of desloratadine in healthy volunteers.

Published in:

Xenobiotica, 2007, v. 37, n. 7, p. 770, doi. 10.1080/00498250701463325

By:

Ramanathan, R.;
Reyderman, L.;
Su, A.-D.;
Alvarez, N.;
Chowdhury, S. K.;
Alton, K. B.;
Wirth, M. A.;
Clement, R. P.;
Statkevich, P.;
Patrick, J. E.

Publication type:

Article

Disposition and pharmacokinetics of temozolomide in rat.

Published in:

Xenobiotica, 2004, v. 34, n. 5, p. 487, doi. 10.1080/00498250410001685737

By:

Reyderman, L.;
Statkevich, P.;
Thonoor, C. M.;
Patrick, J.;
Batra, V. K.;
Wirth, M.

Publication type:

Article

Interaction of single-dose ezetimibe and steady-state cyclosporine in renal transplant patients.

Published in:

2006

By:

Bergman AJ;
Burke J;
Larson P;
Johnson-Levonas AO;
Reyderman L;
Statkevich P;
Maxwell SE;
Kosoglou T;
Murphy G;
Gottesdiener K;
Robson R;
Paolini JF

Publication type:

Journal Article

Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.

Published in:

2006

By:

Bergman AJ;
Burke J;
Larson P;
Johnson-Levonas AO;
Reyderman L;
Statkevich P;
Kosoglou T;
Greenberg HE;
Kraft WK;
Frick G;
Murphy G;
Gottesdiener K;
Paolini JF

Publication type:

Journal Article

PI-69.

Published in:

2006

By:

Tsai, M.;
Reyderman, L.;
Statkevich, P.;
White, R. E.

Publication type:

Case Study

Pharmacokinetics of eribulin mesylate in patients with solid tumors and hepatic impairment.

Published in:

Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 823, doi. 10.1007/s00280-012-1976-x

By:

Devriese, L.;
Witteveen, P.;
Marchetti, S.;
Mergui-Roelvink, M.;
Reyderman, L.;
Wanders, J.;
Jenner, A.;
Edwards, G.;
Beijnen, J.;
Voest, E.;
Schellens, J.

Publication type:

Article

Bioavailability of dextromethorphan (as dextrorphan) from sustained release formulations in the presence of guaifenesin in human volunteers.

Published in:

Biopharmaceutics & Drug Disposition, 1998, v. 19, n. 8, p. 541, doi. 10.1002/(SICI)1099-081X(1998110)19:8<541::AID-BDD138>3.0.CO;2-8

By:

Demirbas, S.;
Reyderman, L.;
Stavchansky, S.

Publication type:

Article

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.

Published in:

2003

By:

Tolcher, A W;
Gerson, S L;
Denis, L;
Geyer, C;
Hammond, L A;
Patnaik, A;
Goetz, A D;
Schwartz, G;
Edwards, T;
Reyderman, L;
Statkevich, P;
Cutler, D L;
Rowinsky, E K

Publication type:

journal article

A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of α integrin inhibitor E7820 in patients with advanced solid tumors.

Published in:

Investigational New Drugs, 2016, v. 34, n. 3, p. 329, doi. 10.1007/s10637-016-0344-9

By:

Milojkovic Kerklaan, B.;
Slater, S.;
Flynn, M.;
Greystoke, A.;
Witteveen, P.;
Megui-Roelvink, M.;
Vos, F.;
Dean, E.;
Reyderman, L.;
Ottesen, L.;
Ranson, M.;
Lolkema, M.;
Plummer, R.;
Kristeleit, R.;
Evans, T.;
Schellens, J.

Publication type:

Article